rhenium has been researched along with Granulocytic Leukemia in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bunjes, D | 1 |
| Bergmann, L; Buchmann, I; Buck, A; Bunjes, D; Döhner, H; Dohr, D; Duncker, C; Glatting, G; Grimminger, W; Harsdorf, SV; Karakas, T; Kotzerke, J; Munzert, G; Reske, SN; Seitz, U; Stefanic, M; Wiesneth, M | 1 |
| Buchmann, I; Buck, A; Bunjes, D; Döhner, H; Glatting, G; Kotzerke, J; Martin, H; Rattat, D; Reske, SN; Seitz, U | 1 |
2 trial(s) available for rhenium and Granulocytic Leukemia
| Article | Year |
|---|---|
188Re-labeled anti-CD66 monoclonal antibody in stem cell transplantation for patients with high-risk acute myeloid leukemia.
Topics: Acute Disease; Adolescent; Adult; Antibodies, Monoclonal; Antigens, CD; Antigens, Differentiation; Bone Marrow Cells; Cell Adhesion Molecules; Combined Modality Therapy; Female; Hematopoietic Stem Cell Transplantation; Humans; Immunoconjugates; Leukemia, Myeloid; Lymphocyte Depletion; Male; Middle Aged; Organ Specificity; Radioimmunotherapy; Radioisotopes; Rhenium; Salvage Therapy; Survival Analysis; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome | 2002 |
Rhenium 188-labeled anti-CD66 (a, b, c, e) monoclonal antibody to intensify the conditioning regimen prior to stem cell transplantation for patients with high-risk acute myeloid leukemia or myelodysplastic syndrome: results of a phase I-II study.
Topics: Acute Disease; Adolescent; Adult; Antibodies, Monoclonal; Antigens, CD; Antigens, Differentiation; Cell Adhesion Molecules; Female; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid; Lymphocyte Depletion; Male; Middle Aged; Myelodysplastic Syndromes; Radioimmunotherapy; Radioisotopes; Rhenium; Risk Factors; T-Lymphocytes; Transplantation Conditioning; Treatment Outcome | 2001 |
1 other study(ies) available for rhenium and Granulocytic Leukemia
| Article | Year |
|---|---|
Myeloablative radioimmunotherapy with Re-188-anti-CD66-antibody for conditioning of high-risk leukemia patients prior to stem cell transplantation: biodistribution, biokinetics and immediate toxicities.
Topics: Adolescent; Adult; Antibodies, Monoclonal; Antigens, CD; Antigens, Differentiation; Bone Marrow; Cell Adhesion Molecules; Female; Hematopoietic Stem Cell Transplantation; Humans; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid; Liver; Lung; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Radiation Dosage; Radioimmunotherapy; Radioisotopes; Radionuclide Imaging; Rhenium; Survival Rate; Tissue Distribution; Transplantation Conditioning | 2002 |